149 related articles for article (PubMed ID: 18437077)
1. Proteomics of pancreatic cancer.
Gräntzdörffer I; Carl-McGrath S; Ebert MP; Röcken C
Pancreas; 2008 May; 36(4):329-36. PubMed ID: 18437077
[TBL] [Abstract][Full Text] [Related]
2. Comparative proteomic analysis of human pancreatic juice: methodological study.
Zhou L; Lu Z; Yang A; Deng R; Mai C; Sang X; Faber KN; Lu X
Proteomics; 2007 Apr; 7(8):1345-55. PubMed ID: 17443640
[TBL] [Abstract][Full Text] [Related]
3. Proteomic technologies and their application to pancreatic cancer.
Vimalachandran D; Costello E
Expert Rev Proteomics; 2004 Dec; 1(4):493-501. PubMed ID: 15966844
[TBL] [Abstract][Full Text] [Related]
4. Clinical cancer proteomics: promises and pitfalls.
Alaiya A; Al-Mohanna M; Linder S
J Proteome Res; 2005; 4(4):1213-22. PubMed ID: 16083271
[TBL] [Abstract][Full Text] [Related]
5. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
6. Plasma proteomic analysis of pancreatic cancer by 2-dimensional gel electrophoresis.
Deng R; Lu Z; Chen Y; Zhou L; Lu X
Pancreas; 2007 Apr; 34(3):310-7. PubMed ID: 17414053
[TBL] [Abstract][Full Text] [Related]
7. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
Bharti A; Ma PC; Salgia R
Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
[TBL] [Abstract][Full Text] [Related]
8. Quantitative proteomic profiling of pancreatic cancer juice.
Chen R; Pan S; Yi EC; Donohoe S; Bronner MP; Potter JD; Goodlett DR; Aebersold R; Brentnall TA
Proteomics; 2006 Jul; 6(13):3871-9. PubMed ID: 16739137
[TBL] [Abstract][Full Text] [Related]
9. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
[TBL] [Abstract][Full Text] [Related]
10. Molecular diagnosis of solid and cystic lesions of the pancreas.
Khalid A; Finkelstein S; McGrath K
Clin Lab Med; 2005 Mar; 25(1):101-16. PubMed ID: 15749234
[TBL] [Abstract][Full Text] [Related]
11. Proteome informatics for cancer research: from molecules to clinic.
Brusic V; Marina O; Wu CJ; Reinherz EL
Proteomics; 2007 Mar; 7(6):976-91. PubMed ID: 17370257
[TBL] [Abstract][Full Text] [Related]
12. A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers.
Gortzak-Uzan L; Ignatchenko A; Evangelou AI; Agochiya M; Brown KA; St Onge P; Kireeva I; Schmitt-Ulms G; Brown TJ; Murphy J; Rosen B; Shaw P; Jurisica I; Kislinger T
J Proteome Res; 2008 Jan; 7(1):339-51. PubMed ID: 18076136
[TBL] [Abstract][Full Text] [Related]
13. Synuclein-gamma is closely involved in perineural invasion and distant metastasis in mouse models and is a novel prognostic factor in pancreatic cancer.
Hibi T; Mori T; Fukuma M; Yamazaki K; Hashiguchi A; Yamada T; Tanabe M; Aiura K; Kawakami T; Ogiwara A; Kosuge T; Kitajima M; Kitagawa Y; Sakamoto M
Clin Cancer Res; 2009 Apr; 15(8):2864-71. PubMed ID: 19351749
[TBL] [Abstract][Full Text] [Related]
14. Application of proteomics in ovarian cancer: which sample should be used?
Cadron I; Van Gorp T; Timmerman D; Amant F; Waelkens E; Vergote I
Gynecol Oncol; 2009 Dec; 115(3):497-503. PubMed ID: 19811810
[TBL] [Abstract][Full Text] [Related]
15. Epithelial proteomics in multiple organs and tissues: similarities and variations between cells, organs, and diseases.
Zhao H; Adler KB; Bai C; Tang F; Wang X
J Proteome Res; 2006 Apr; 5(4):743-55. PubMed ID: 16602680
[TBL] [Abstract][Full Text] [Related]
16. High-performance proteomics as a tool in biomarker discovery.
Meyer HE; Stühler K
Proteomics; 2007 Sep; 7 Suppl 1():18-26. PubMed ID: 17893859
[TBL] [Abstract][Full Text] [Related]
17. Proteomics: new technologies and clinical applications.
Latterich M; Abramovitz M; Leyland-Jones B
Eur J Cancer; 2008 Dec; 44(18):2737-41. PubMed ID: 18977654
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic cancer: proteomic approaches to a challenging disease.
Tonack S; Aspinall-O'Dea M; Neoptolemos JP; Costello E
Pancreatology; 2009; 9(5):567-76. PubMed ID: 19657212
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of human bile from malignant biliary stenosis induced by pancreatic cancer.
Farina A; Dumonceau JM; Frossard JL; Hadengue A; Hochstrasser DF; Lescuyer P
J Proteome Res; 2009 Jan; 8(1):159-69. PubMed ID: 19055478
[TBL] [Abstract][Full Text] [Related]
20. Current proteomic analysis and post-translational modifications of biomarkers in human lung cancer materials.
Sinchaikul S; Hongsachart P; Sriyam S; Tantipaiboonwong P; Phutrakul S; Chen ST
Chang Gung Med J; 2008; 31(5):417-30. PubMed ID: 19097588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
